The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arjan Lalchandani
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Arjan Lalchandani, the Managing Director and Promoter of Dr Lalchandani Labs Ltd, has sold 44,000 equity shares of the company through the open market between September 01, 2025 and September 04, 2025. This represents 1.02% of the company's total share capital. As a result, his holding decreased from 11,54,851 shares (26.65%) to 11,10,851 shares (25.64%). The disclosure was filed under SEBI's Takeover Regulations, which require promoters to report any change in holding exceeding 2% in a financial year, though this 1.02% transaction is still being voluntarily reported.
This is a relatively small open-market sale by the promoter (just over 1% of equity), so the direct price impact is likely limited. However, retail investors may view any promoter selling as a mild negative signal regarding the promoter's confidence in near-term valuations.